|
1
|
Esiashvili N, Goodman M and Marcus RB Jr:
Changes in incidence and survival of Ewing sarcoma patients over
the past 3 decades: Surveillance Epidemiology and End Results data.
J Pediatr Hematol Oncol. 30:425–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gaspar N, Hawkins DS, Dirksen U, Lewis IJ,
Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, et
al: Ewing sarcoma: Current management and future approaches through
collaboration. J Clin Oncol. 33:3036–3046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iwamoto Y: Diagnosis and treatment of
Ewing's sarcoma. Jpn J Clin Oncol. 37:79–89. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Widhe B and Widhe T: Initial symptoms and
clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint
Surg Am. 82:667–674. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balamuth NJ and Womer RB: Ewing's sarcoma.
Lancet Oncol. 11:184–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Newman DJ, Cragg GM, Gao Y, Du Z, Wang Y,
Cheng P, Chen A and Huang H: Natural products as sources of new
drugs over the last 25 years. J Nat Prod. 70:461–477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cassileth B, Yeung KS and Gubili J: Herbs
and other botanicals in cancer patient care. Curr Treat Options
Oncol. 9:109–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu X, Zhou X, Fu C, Wang Q, Nie T, Zou F,
Guo R, Liu H, Zhang B and Dai M: Celastrol induces apoptosis of
human osteosarcoma cells via the mitochondrial apoptotic pathway.
Oncol Rep. 34:1129–1136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li-Weber M: New therapeutic aspects of
flavones: The anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar
|
|
11
|
Wang L, Ling Y, Chen Y, Li CL, Feng F, You
QD, Lu N and Guo QL: Flavonoid baicalein suppresses adhesion,
migration and invasion of MDA-MB-231 human breast cancer cells.
Cancer Lett. 297:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang RR, Zhang S, Qi JA, Wang ZD, Li J,
Liu PJ, Huang C, Le XF, Yang J and Li ZF: Preferential inhibition
of hepatocellular carcinoma by the flavonoid Baicalein through
blocking MEK-ERK signaling. Int J Oncol. 41:969–978. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Z, Otsuyama K, Liu S, Abroun S,
Ishikawa H, Tsuyama N, Obata M, Li FJ, Zheng X, Maki Y, et al:
Baicalein, a component of Scutellaria radix from
Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of
proliferation and induction of apoptosis in human myeloma cells.
Blood. 105:3312–3318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chai Y, Xu J and Yan B: The
anti-metastatic effect of baicalein on colorectal cancer. Oncol
Rep. 37:2317–2323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang K, Wang X, Wang C, Zheng H, Li T,
Xiao S, Wang M, Fei C, Zhang L and Xue F: Investigation of
quinocetone-induced mitochondrial damage and apoptosis in HepG2
cells and compared with its metabolites. Environ Toxicol Pharmacol.
39:555–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Song J, Wu D, Wang J and Dong W:
Hesperetin induces the apoptosis of hepatocellular carcinoma cells
via mitochondrial pathway mediated by the increased intracellular
reactive oxygen species, ATP and calcium. Med Oncol. 32:1012015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pieme CA, Santosh GK, Tekwu EM, Askun T,
Aydeniz H, Ngogang JY, Bhushan S and Saxena AK: Fruits and barks
extracts of Zanthozyllum heitzii a spice from Cameroon induce
mitochondrial dependent apoptosis and Go/G1 phase arrest in human
leukemia HL-60 cells. Biol Res. 47:542014. View Article : Google Scholar
|
|
18
|
Chang WH, Chen CH, Gau RJ, Lin CC, Tsai
CL, Tsai K and Lu FJ: Effect of baicalein on apoptosis of the human
Hep G2 cell line was induced by mitochondrial dysfunction. Planta
Med. 68:302–306. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong WG, Ding XZ and Adrian TE: The
mechanisms of lipoxygenase inhibitor-induced apoptosis in human
breast cancer cells. Biochem Biophys Res Commun. 296:942–948. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lorenzo HK and Susin SA: Therapeutic
potential of AIF-mediated caspase-independent programmed cell
death. Drug Resist Updat. 10:235–255. 2007. View Article : Google Scholar
|
|
22
|
Chang HY and Yang X: Proteases for cell
suicide: Functions and regulation of caspases. Microbiol Mol Biol
Rev. 64:821–846. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao X, Bennett RL and May WS: c-Myc and
caspase-2 are involved in activating Bax during cytotoxic
drug-induced apoptosis. J Biol Chem. 283:14490–14496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stennicke HR and Salvesen GS: Properties
of the caspases. Biochim Biophys Acta. 1387:17–31. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hui KK, Kanungo AK, Elia AJ and Henderson
JT: Caspase-3 deficiency reveals a physiologic role for Smac/DIABLO
in regulating programmed cell death. Cell Death Differ.
18:1780–1790. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gillies LA and Kuwana T: Apoptosis
regulation at the mitochondrial outer membrane. J Cell Biochem.
115:632–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jourdain A and Martinou JC: Mitochondrial
outer-membrane permeabilization and remodelling in apoptosis. Int J
Biochem Cell Biol. 41:1884–1889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wood WG, Igbavboa U, Muller WE and Eckert
GP: Statins, Bcl-2, and apoptosis: Cell death or cell protection?
Mol Neurobiol. 48:308–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Villa-Morales M and Fernández-Piqueras J:
Targeting the Fas/FasL signaling pathway in cancer therapy. Expert
Opin Ther Targets. 16:85–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gordon N and Kleinerman ES: Aerosol
therapy for the treatment of osteosarcoma lung metastases:
Targeting the Fas/FasL pathway and rationale for the use of
gemcitabine. J Aerosol Med Pulm Drug Deliv. 23:189–196. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li H, Zhang K, Liu LH, Ouyang Y, Bu J, Guo
HB and Xiao T: A systematic review of matrix metalloproteinase 9 as
a biomarker of survival in patients with osteosarcoma. Tumour Biol.
35:5487–5491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Shi Q, Yuan TX, Song QL, Zhang Y,
Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix
metalloproteinase 9 (MMP-9) in osteosarcoma: Review and
meta-analysis. Clin Chim Acta. 433:225–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shang HS, Chang JB, Lin JH, Lin JP, Hsu
SC, Liu CM, Liu JY, Wu PP, Lu HF, Au MK, et al: Deguelin inhibits
the migration and invasion of U-2 OS human osteosarcoma cells via
the inhibition of matrix metalloproteinase-2/-9 in vitro.
Molecules. 19:16588–16608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He N and Zhang Z: Baicalein suppresses the
viability of MG-63 osteosarcoma cells through inhibiting c-MYC
expression via Wnt signaling pathway. Mol Cell Biochem.
405:187–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen F, Zhuang M, Peng J, Wang X, Huang T,
Li S, Lin M, Lin H, Xu Y, Li J, et al: Baicalein inhibits migration
and invasion of gastric cancer cells through suppression of the
TGF-β signaling pathway. Mol Med Rep. 10:1999–2003. 2014.
View Article : Google Scholar : PubMed/NCBI
|
